Tag Archives: incyte

October, 2018

September, 2018

July, 2018

June, 2018

April, 2018

January, 2018

October, 2017

  • 26 October

    Incyte and MacroGenics Collaborate for Anti-PD-1 Monoclonal Antibody MGA012

    WILMINGTON, Del. & ROCKVILLE, Md.–(BUSINESS WIRE)–Incyte Corporation (NASDAQ:INCY) and MacroGenics, Inc. (NASDAQ:MGNX) announced today that the companies have entered into an exclusive global collaboration and license agreement for MacroGenics’ MGA012, an investigational monoclonal antibody that inhibits programmed cell death protein 1 (PD-1). Incyte has obtained exclusive worldwide rights for the …

June, 2017

April, 2017